VEGFA and familial pancreatic carcinoma: Similar results have also been reported in the clinic where targeted anti-VEGF treatment in pancreatic cancer was not successful, and failure of DC101 to Veh-ctrl tumors in our study mirrors these findings where inhibition of a single target was insufficient to achieve tumor control [38].